|
PMS2L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.39830000093156E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.38940000008014E-07 |
| Normal-vs-Stage2 |
4.996100E-03 |
| Normal-vs-Stage3 |
2.234400E-02 |
| Normal-vs-Stage4 |
9.583000E-04 |
| Stage1-vs-Stage2 |
7.750800E-01 |
| Stage1-vs-Stage3 |
1.005840E-01 |
| Stage1-vs-Stage4 |
9.544400E-01 |
| Stage2-vs-Stage3 |
3.695800E-01 |
| Stage2-vs-Stage4 |
7.747200E-01 |
| Stage3-vs-Stage4 |
1.923200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.55630000009799E-07 |
| Normal-vs-AfricanAmerican |
4.826500E-04 |
| Normal-vs-Asian |
4.523600E-01 |
| Caucasian-vs-AfricanAmerican |
1.622960E-01 |
| Caucasian-vs-Asian |
8.215800E-01 |
| AfricanAmerican-vs-Asian |
4.818000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.0006999999509E-06 |
| Normal-vs-Female |
1.33820000003393E-06 |
| Male-vs-Female |
3.691400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.192400E-02 |
| Normal-vs-Age(41-60Yrs) |
4.03290000000611E-05 |
| Normal-vs-Age(61-80Yrs) |
1.89913999999458E-05 |
| Normal-vs-Age(81-100Yrs) |
5.199300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.690600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.040800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.890800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.906400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.226400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.060200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.596240E-01 |
| Normal-vs-Grade 2 |
2.15770000000504E-06 |
| Normal-vs-Grade 3 |
2.25889999999618E-05 |
| Normal-vs-Grade 4 |
1.060280E-02 |
| Grade 1-vs-Grade 2 |
7.146800E-01 |
| Grade 1-vs-Grade 3 |
7.601000E-01 |
| Grade 1-vs-Grade 4 |
6.651200E-01 |
| Grade 2-vs-Grade 3 |
9.495200E-01 |
| Grade 2-vs-Grade 4 |
7.575200E-01 |
| Grade 3-vs-Grade 4 |
7.476800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.65460001255724E-09 |
| Normal-vs-ccB subtype |
6.594300E-02 |
| ccA subtype-vs-ccB subtype |
5.188300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.21220000002398E-07 |
| Normal-vs-N1 |
1.055420E-01 |
| N0-vs-N1 |
7.472600E-01 |
|
|
